A novel method for the direct determination of heparin concentration during cardiopulmonary bypass surgery

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 10, 2013, Pages 2037-2043

  Haselbach, Stephanie ^a   Maurer, Jürgen ^a   Vogel, Vitali ^a   Harder, Sebastian ^b   Weber, Christian Friedrich ^b   Baykut, Doan ^a   Meininger, Dirk ^b   Keller, Harald ^b   Moritz, Anton ^b   Mäntele, Werner ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Activated clotting time; Anticoagulation; Cardiopulmonary bypass; Extracorporeal circulation; Heparin; Protamine

Indexed keywords

FRESH FROZEN PLASMA; GLYCERYL TRINITRATE; HEPARIN; PROTAMINE; THROMBOCYTE CONCENTRATE;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS SURGERY; DRUG BLOOD LEVEL; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; HUMAN TISSUE; LIGHT SCATTERING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; THORACOTOMY; THROMBOCYTE TRANSFUSION;

AGED; ANTICOAGULANTS; BIAS (EPIDEMIOLOGY); BIOLOGICAL ASSAY; CARDIOPULMONARY BYPASS; DRUG MONITORING; FEMALE; HEPARIN; HUMANS; LIGHT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SCATTERING, RADIATION; SENSITIVITY AND SPECIFICITY; WHOLE BLOOD COAGULATION TIME;

EID: 84888123518     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0278     Document Type: Article

References (27)

1. Harenberg J, Fenyvesi T. Heparin, thrombin and Factor Xa inhibitors. Hamostaseologie 2004;24: 261-78.
2. Baglin T, Barrowcliffe TW, Cohen A, Greaves M. Guidelines on the use and monitoring of heparin. Br J Haematol 2006;133: 19-34. (Pubitemid 43327194)
3. Gray E, Mulloy B, Barrowcliffe TW. Heparin and low-molecularweight heparin. Thromb Haemost 2008;99: 807-18.
4. Shaughnessy SG, Young E, Deschamps P, Hirsh J. The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria. Blood 1995;86: 1368-73.
5. Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med 2004;30: 1873-81. (Pubitemid 39468407)
6. Bull BS, Hay KL, Herrmann PC. Postoperative bypass bleeding: a bypass-associated dilutional (BAD) coagulopathy? Blood Cells Mol Dis 2009;43: 256-9.
7. Machin D, Devine P. The effect of temperature and aprotinin during cardiopulmonary bypass on three different methods of activated clotting time measurement. J Extra Corpor Technol 2005;37: 265-71. (Pubitemid 43160405)
8. Despotis GJ, Levine V, Joist JH, Joiner-Maier D, Spitznagel E. Antithrombin III during cardiac surgery: effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation. Anesth Analg 1997;85: 498-506. (Pubitemid 27381298)
9. Koerber JM, Smythe MA, Begle RL, Mattson JC, Kershaw BP, Westley SJ. Correlation of activated clotting time and activated partial thromboplastin time to plasma heparin concentration. Pharmacotherapy 1999;19: 922-31. (Pubitemid 29377310)
10. De Waele JJ, Van Cauwenberghe S, Hoste E, Benoit D, Colardyn F. The use of the activated clotting time for monitoring heparin therapy in critically ill patients. Intensive Care Med 2003;29: 325-8. (Pubitemid 36384426)
11. Mochizuki T, Olson PJ, Szlam F, Ramsay JG, Levy JH. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Anesth Analg 1998;87: 781-5. (Pubitemid 28455470)
12. Schapira M, Christman BW. Neutralization of heparin by protamine. Time for a change? Circulation 1990;82: 1877-9. (Pubitemid 20367996)
13. Velders AJ, Wildevuur CR. Platelet damage by protamine and the protective effect of prostacyclin: an experimental study in dogs. Ann Thorac Surg 1986;42: 168-71. (Pubitemid 16035262)
14. Park KW. Protamine and protamine reactions. Int Anesthesiol Clin 2004;42: 135-45. (Pubitemid 38963099)
15. Horrow JC. Protamine: a review of its toxicity. Anesth Analg 1985;64: 348-61. (Pubitemid 15130775)
16. Stewart WJ, McSweeney SM, Kellett MA, Faxon DP, Ryan TJ. Increased risk of severe protamine reactions in NPH insulindependent diabetics undergoing cardiac catheterization. Circulation 1984;70: 788-92. (Pubitemid 15205442)
17. Beholz S, Grubitzsch H, Bergmann B, Wollert HG, Eckel L. Hemostasis management by use of Hepcon/HMS: increased bleeding without increased need for blood transfusion. Thorac Cardiovasc Surg 1999;47: 322-7.
18. Aziz KA, Masood O, Hoschtitzky JA, Ronald A. Does use of the Hepcon point-of-care coagulation monitor to optimise heparin and protamine dosage for cardiopulmonary bypass decrease bleeding and blood and blood product requirements in adult patients undergoing cardiac surgery? Interact Cardiovasc Thorac Surg 2006;5: 469-82. (Pubitemid 44166463)
19. Wahr JA, Yun JH, Yang VC, Lee LM, Fu B, Meyerhoff ME. A new method of measuring heparin levels in whole blood by protamine titration using a heparin-responsive electrochemical sensor. J Cardiothorac Vasc Anesth 1996;10: 447-50. (Pubitemid 26177751)
20. Maurer J, Haselbach S, Klein O, Baykut D, Vogel V, Mäntele W. Analysis of the complex formation of heparin with protamine by light scattering and analytical ultracentrifugation: implications for blood coagulation management. J Am Chem Soc 2011;133: 1134-40.
21. Baykut D, Haselbach S, Maurer J, Vogel V, Klein O, Mäntele W. Exact heparin level in blood - novel light-scattering analysis makes the intraoperative direct determination possible. Thorac Cardiovasc Surg 2012;60:87.
22. Hardy JF, Bélisle S, Robitaille D, Perrault J, Roy M, Gagnon L. Measurement of heparin concentration in whole blood with the Hepcon/HMS device does not agree with laboratory determination of plasma heparin concentration using a chromogenic substrate for activated factor X. J Thorac Cardiovasc Surg 1996;112: 154-61. (Pubitemid 26268982)
23. Linkins LA, Julian JA, Rischke J, Hirsh J, Weitz JI. In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation. Thromb Res 2002;107: 241-4. (Pubitemid 35435383)
24. Ramamurthy N, Baliga N, Wahr JA, Schaller U, Yang VC, Meyerhoff ME. Improved protamine-sensitive membrane electrode for monitoring heparin concentrations in whole blood via protamine titration. Clin Chem 1998;44: 606-13. (Pubitemid 28141359)
25. Kehrel B. Hemostasis management based on ROTEM: contra. Anasthesiol Intensivmed Notfallmed Schmerzther 2011;46: 318-22.
26. Raivio P, Kuitunen A, Petäjä J, Ilveskero S, Lassila R. Monitoring high-dose heparinization during cardiopulmonary bypass - a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays. Thromb Haemost 2008;99: 427-34. (Pubitemid 351230975)
27. Junker R, Schlebusch H, Luppa PB. Point-of-care testing in hospitals and primary care. Dtsch Arztebl Int 2010;107: 561-7.